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1. Introduction 
Syphilis is still a public health problem in the world. The World Health Organization 
estimated that approximately 12 million new cases are reported each year in the world with 
more than 90 percent from developing countries (Centers for Disease Control [CDC], 2007; 
World Health Organization [WHO], 2001). Moreover, syphilis has acquired a higher 
potential of morbidity and mortality with the increasing prevalence of HIV infection. If 
syphilis is rare in developed countries, it is much more common in developing countries 
where prevalence can reach 25% amongst blood donors (Tagny & al., 2009, 2010).The 
infection is transmitted from person to person through contact with a syphilis ulcer (during 
vaginal, anal, or oral sex). An infected mother can infect her fetus via the placenta. 
Furthermore, intravenous drug addicts or other infected person can transmit syphilis 
through infected blood products i.e. through blood transfusion or use of infected needles for 
example (Workowski & Berman, 2006). 
2. Transfusion transmissibility of syphilis 
Fordyce reported the first case of transfusion-transmitted syphilis in 1915. More than 100 
cases have subsequently been reported in different countries including USA and Great 
Britain (CDC, 2004; Henneberg M. & Henneberg R.J., 1994; Lobdell & al., 1974). However, 
the numbers of transfusion-transmitted syphilis cases has decreased all over the world. In 
the past 35 years, only three cases of transfusion-transmitted syphilis have been reported in 
the English literature and the last one was reported since more than forty years ago in USA 
(Brant & al., 2007; CDC, 2004; Chambers & al., 1969; Hook & Peeling, 2004). The absence of 
transfusion-transmitted syphilis in many developed countries leads to question the rationale 
for continuing syphilis testing of blood donors.  
Syphilis is a transfusion-transmitted infection (TTI) due to a spirocheta called Treponema 
pallidum. The germ is present in the blood of a contaminated blood donor and infects the 
recipient. The transmissibility of syphilis by blood transfusion has been frequently reported, 
chiefly based on animal experiments. Cases of syphilis transmitted by blood have been 
described in literature, with more than a hundred cases since the first description. The main 
cases reported were shown to occur when donors were in the primary or secondary stage of 
the disease. (Gardella & al., 2002; Orton, 2001; Risseeuw-Appel & Kothe, 1983; Singh & 
Romanowski, 1999; Soendjojo & al., 1982). T. pallidum may be found in the blood stream, but 
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levels are variable, and bacteremia is often short-lived even in recent contamination. 
Moreover, the treponemes are relatively fragile and sensitive to cold; storage below +20°c 
for more than 72 hours destroys the organism and reduces dramatically the infectious risk. 
Although clearly potentially infectious, the risk of transmission through the transfusion of 
blood and blood components stored below +20°c is very low (Orton, 2001; Wendel, 1994). 
Platelet concentrates usually stored at a temperature above +20°C or blood directly 
transfused few hours after collection comprises a higher risk of transmitting syphilis. This is 
the case in many developing countries with limited blood supply where blood is collected 
from family donors and frequently transfused in the following hours or days. Thus, the 
screening test is considered essential as most blood transfusion services are concerned by 
storage of blood products stored either above +20°C or not stored below +20°C for more 
than 4 days. Furthermore, it is actually shown that the deferral of blood products screened 
positive also reduces the risk of contamination from HIV and HBV. 
When the germ is transmitted to the recipient, some signs appear  a few weeks later notably 
macular lesions on the palms,  headache, arthralgia, fever, headache, peripheral lymphs 
nodes and more rarely jaundice. For all the reported cases, there was neither a history of 
venereal disease nor presence of sores on the blood donor at the time of donation. However, 
many cases were associated with appearance of a sore on the blood donor few days after the 
donation. Thus, syphilis can be transmitted from donors who are clinically and biologically 
negative. It is clear that medical selection and mainly information and questionning are 
essential to identify those who have been exposed to infection during the preceding two 
months.  
Some other diseases are caused by other species or subspecies of Treponema: Yaws 
(Treponema pertenue), Pinta (Treponema carateum) and Bejel (Treponema endemicum). Yaws and 
pinta may potentially be transmitted by transfusion, but few data is available. Bejel is 
unlikely to be transmitted and infect individuals (Chambers & al., 1969; Wendel, 1994). 
These diseases  usually have clear symptoms that would lead to donor deferral. 
Strategies of safety were proposed and modified during the years until the adoption in 1987 
by the WHO of a common international strategy. Several steps and strategies were 
elaborated as well by the international organizations (WHO, the International Society of 
Blood Transfusion, the American Association of Blood Banks) and the blood banks. Their 
general recommendations focus on the control of the bacterial dissemination of the disease 
through blood transfusion by the selection of low risk blood donors and the screening of the 
disease by efficient lab tests. The strategies of reduction of this risk of transfusion 
transmissible infections associates the natural medical selection the effective biological 
qualification, the reduction of pathogens by a physico-chemical treatment of the products 
and the rational use of the prepared products. However, blood safety begins by the 
implementation of organized blood centres, of a quality system, hemovigilance, and 
application of safety measures in transfusion. The organization of blood centres is related to 
the implementation of blood supply programs and blood safety strategies by a well-
organized centre, national or regional. Blood banks are frequently used as a base of 
transfusion. A Quality system includes management, training, norms, documentation 
traceability and evaluation. Haemovigilance is defined as a set of organized surveillance 
procedures relating to adverse or unexpected events or reactions in donors or recipients. In 
the transfusion chain, the first to be considered is the safe blood donor. 
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3. Syphilis and blood donor 
Blood donors with high-risk sexual behaviour and other risk factors may be infected by 
syphilis and compromise the safety of blood used for transfusion. The medical selection of 
the blood donors consists of information of the donor, the finding of the risk factors in the 
behaviours and the medical history using a questionnaire, the physical examination in order 
to find clinical signs of the infection. Donor deferral follows identification of any risk. 
Medical selection is crucial because it could permit to defer more than half of infected 
donors, especially the ones in the early period of infection here laboratory tests are not 
efficient (de Almeida Neto & al, 2007; Tagny, 2009). 
In some European countries, the prevalence of T. pallidum infection in the general 
population and thus in blood donors has been increasing since last two decades. An increase 
in syphilis infections has been associated to the high incidence of HIV. Moreover, an 
infected blood donor with syphilis is more than 5 times more likely to be HIV-positive. 
However, the prevalence of syphilis is still very low in developed countries and the very 
rare cases of recipient contamination raised the question of whether syphilis screening was 
still necessary for blood donors. In developing countries, the prevalence of positive serologic 
tests for syphilis can reach 25%. The prevalence is however very variable from one area to 
another and from a country to another. In such settings, the poor quality of laboratory 
screening due to the lack of equipment, training personnel, reagents and standard 
procedures highlights the need of the systematic and better screening for syphilis to help 
ensure a safer blood supply. Very little systematic information is available on the profile of 
positive blood donors including differences between donors with recent versus past 
infection. The exclusion of donors with past and treated infection is still a matter of 
discussion. Abusive exclusion reduces the blood supply and could be problematic in 
developing countries. However, past history of syphilis may be high-risk sexual behaviour 
associated to transmitted transfusion infection such as syphilis itself and HIV. The 
transfusion risk of syphilis is closely related to risk factors in the blood donor, in particular 
the sexual behaviours, the disease being primarily transmitted by sexual route. The rates of 
infection are highest amongst homosexual (gay) men - or men who have sex with men (Vall-
Mayans & al, 2006). Recent syphilis infections have been shown to be associated with 
younger age, male-male sex, two or more sex partners, past syphilis treatment, past syphilis 
history, HIV seropositivity. Risk factors usually associated with transfusion transmitted 
syphillis also include more than one sexual partner, prostitution, bisexuality ( men having 
sex with both men and women), intravenous drug use, and skin scarification (tattoing,blood 
rituals).  
In developing countries, most blood donors infected are first-time donors. The prevalence of 
syphilis is one of the highest amongst the TTI screened in developing countries. The 
problem of this disease, first of all, is its high prevalence in blood donors in various areas of 
Africa. The recent prevalence were 3.7 % in Congo (Batina & al 2007), 7.9 % in Ghana (Adjei 
& al., 2003; Ampofo & al., 2002) and 9.1 % in Cameroon (Mbanya & al., 2003; Tagny & al., 
2009). It is just as high in females as in males, in the different age groups and in voluntary 
donor as well as family donors. The family blood donation and remunerated blood 
donation, mostly found in developing countries is statiscally associated with higher 
prevalence of the disease (Batina & al., 2007; Tagny & al., 2010). The donors who have been 
positive for syphilis during the previous donation are less likely to donate again, whereas 
donors who were negative for the presence of syphilis in the past would be more likely to 
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donate again. In countries, which use a medical questionnaire for selection of blood donor, 
there are usually questions related to infection with syphilis. These questions concentrate 
particularly on sexual behavior (a number of sexual partners, use of condoms, past history 
of sexually transmitted diseases) and sometimes on specific symptoms observed during 
clinical examination. However, medical selection remains ineffective for several reasons:  
- Difficulty of understanding the questions due to the level of education (ignorance of the 
transmissible infections by blood transfusion) (Nébié & al., 2007; Agbovi & al., 2006), 
linguistic and cultural (taboos) barriers;  
- Discrete expression of the disease in its primary phase. The syphilitic rosella is not 
clearly visible on dark skin.  
- Suppression of clinical signs and symptoms by the various antibiotics following self - 
medication (ampicilline, penicillin). Thus, the biological screening of this disease 
remains essential to defer blood donors at risk.  
Identified safe donors must be retained in the pool of repeated donors and frequently 
informed and educated to avoid risky behaviours.  
4. Syphilis and screening of blood donation 
Serological tests for syphilis contributed greatly to the detection of T. pallidum infection in 
blood donors and especially in those who were not identified during the medical selection. 
Wasserman (Henneberg M. & Henneberg R.J., 1994; Rose & al., 1997) developed the first test 
of syphilis in 1906. Although it had some false positive results, it was a major advancement 
in the prevention of syphilis because it helped to diagnose the disease before the clinical 
manifestation and thus prevent its spread. In the 1930s the Hinton test, developed by 
William Augustus Hinton, and based on flocculation, was shown to be more specific than 
the Wassermann test. At the beginning of the 20th century newer tests were developed. 
Present-day, several labs tests, treponemic or not treponemic exist, among which rapid tests, 
immunological tests, and genomic (Young & al., 2000). Neither there is a specific type of 
method absolutely indicated, nor is there any confirmatory algorithm for testing based on 
the different assays available. In fact, the laboratory assessment of syphilis is generally 
based on the detection of antibodies against T. pallidum antigens in blood by the use of either 
specific or nonspecific reagents. The detection of genomic particle are more specific but not 
affordable for most of laboratories (Marfin & al., 2001; Orton & al. 2002).  
The detection of specific Treponema antigens is possible using methods as passive 
agglutination, as  T. pallidum hemagglutination (TPHA) assay or the T. pallidum particle 
agglutination (TPPA) assay, indirect immunofluorescence as the fluorescent treponemal 
antibody absorbed (FTA-ABS) assay or  enzyme immunoassay (EIA) for the detection of 
specific IgG and IgM or total Ig. Non-treponemal methods are based on non-treponemal 
lipid antigens (cardiolipin), using frequently the flocculation technique. Of these, the 
Venereal Disease Research Laboratory (VDRL) and rapid plasma reagin (RPR) tests are the 
most commonly used. These tests are cheap, fast and more sensitive (Montoya & al. 2006; 
WHO, 2006). They are able to identify the contaminated blood donors few days before the 
treponemal test and thus useful for acute infection. However, VDRL and RPR cannot be 
automated and are time-consuming if used for large scale testing. Moreover, they produce 
more false positive results. These tests are routinely used to screen blood donors. False 
positives on the rapid tests can be seen in viral infections such as hepatitis, tuberculosis, 
malaria, or varicella. Thus, non-treponemal tests should be followed up when possible by a 
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treponemal test. The treponemal tests are based on monoclonal antibodies and 
immunofluorescence; they are more specific and more expensive. The tests based on 
enzyme-linked immunoassays are the more specific and are usually used to confirm the 
results of simpler screening tests for syphilis. According to the guidelines published by the 
U.S. Centers for Disease Control and Prevention, the diagnosis of syphilis should be based 
on the results of at least two tests: one treponemal and the other non treponemal (CDC, 
2006; CDC, 2004 ). According to WHO, blood banks may choose Venereal Disease Research 
Laboratory (VDRL), rapid plasma reagin (RPR), or enzyme immunoassay (EIA). VDRL and 
RPR are sensitive for recent syphilis infection, but not for past infection. Screening should be 
performed using a highly sensitive and specific test for treponemal antibodies: either TPHA 
or enzyme immunoassay. In populations where there is a high incidence of syphilis, 
screening should be performed using a non-treponemal assay: VDRL or RPR. EIA can detect 
past or recent infection, but may result in rejecting non-infectious blood with distant past 
infection (Cole & al., 2007). However, one should remember that the reliability of the 
screening and the diagnosis include  the performances as well as the quality assessment 
notably the use of standard operating procedures, norms, training of the personnel and 
management of quality.  
The screening for syphilis is frequently carried out on the African blood donor, and national 
policies often include the disease in the list of ITT to be screened at the time of blood 
donation. More than 90 % of blood collected in Africa in the year 2004 was screened for 
syphilis (Tapko & al., 2005). The techniques used for screening are different from one 
country to another:  VDRL or RPR alone for some, VDRL + TPHA for others (Tagny, 2009). 
Developing countries are characterized by a difficult epidemiologic, sociological and 
economic environment which limits the implementation of a high quality of blood safety. 
Thus, this context requires that tests and algorithms should be selected so that they 
correspond with the high prevalence of the disease, limited technical know-how of the 
personnel and limited availability of reagents and equipments. The selection criteria of 
screening strategy must include simple techniques, reliability, sustainability and cost 
effectiveness. Regular supply of electricity, freezer and ELISA kits is mostly found in big 
cities and barely available in small towns. Several blood banks use rapid test technique as it 
does not required sophisticated lab materials (Tagny & al., 2009). Screening strategies must 
also take into account the training of technicians, guarantee their capacity to carry out the 
test and provide reliable results.  
5. Other blood safety issues 
The good clinical use of the blood products is an essential stage of blood safety with respect 
to syphilis. It relates to the definition and the respect of the indications of transfusion, but 
also recording, analysis and diffusion of adverse reactions due to the infection. Each blood 
bank or transfusion service (national or regional) is responsible for ensuring blood safety to 
their patients. They should minimize unnecessary transfusions by prevention of conditions 
that result in the need for transfusion, reduce blood loss by using good surgical and 
anaesthetic techniques, or use simple alternatives for volume replacement. These strategies 
could be done with the help of organisations such as transfusion committees in each 
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Blood safety also consists of the use of physico-chemical treatment (filter on blood bag, use 
of amotosalen or ribavirin). This treatment of donated blood has shown its capacity to 
reduce the transmissibility of many germs especially in plasma and platelets. Once inside 
the pathogen, amotosalen or ribavirin docks in between the nucleic acid base pairs and 
blocks irreversibly the replication of DNA and ARN, thus preventing the proliferation. The 
physico-chemical treatment cannot be used on erythrocytes and are costly, thus less suitable 
for resources limited countries where whole blood and red blood cell concentrates are 
mostly used. 
6. Conclusion  
The challenge and perspectives of syphilis during transfusion is related to improvement of 
clinical selection of blood donor (identifying the precise risk factors) and to development of 
tools for the treatment of red blood cell concentrates. Syphills was the first infectious agent 
shown to be transmitted by blood transfusion  and, in the past, there was a reasonably 
significant number of transmissions. Occasional cases still occur even today in some 
countries with a high incidence of syphillis. However, it is very unlikely that transfusion has 
ever been a major factor in the spread of the disease. In low incidence countries, the vast 
majority of cases of syphillis identified in blood donors are due to old infections that have 
been treated succesfully and present no risk of transfusion transmission. With the exclusion 
of high risk donors, screening for T. pallidum and storage of most blood components at or 
below +4°C before transfusion, makes the risk of post transfusion syphilis almost negligible 
in many countries. The challenges and the perspectives of the disease during transfusion are 
related to improvement clinical selection of blood donor (identifying the precise risk factors) 
and to the development of tools for treatment of red blood cell concentrates. 
Prevention of the spread of syphillis is primarily by education and developpement of 
effective and treatment programmes. All patients with syphilis should be tested for HIV. 
Sexually transmitted diseases in general are the major route of infection while transfusion is 
only a minor route. Eliminating high risk sexual behaviours is very effective in helping 
prevent Syphilis. Proper and consistent use of a latex condom can also reduce the spread of 
syphilis. Moreover, donors sexually exposed to a person with primary, secondary, or early 
latent syphilis within 90 days preceding the diagnosis should be assumed to be infected. 
They should be treated and educated, even if they are seronegative at the time of donation. 
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